読み込み中
NASDAQHealthcareMedical - Devices
最新データ
$61.67
+$1.06 · +1.75%
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
前日終値
$61.67
+$1.06 · +1.75%
日中の時刻はETです。市場データは遅延する場合があります。
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
日中レンジ
現在 $61.67
52週レンジ
現在 $61.67
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
64
割安
センチメント
45
まちまち
リスク
36
中程度のリスク
モメンタム
59
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
日中レンジ
現在 $61.67
52週レンジ
現在 $61.67
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 2.11億 USD | 1.66億 USD | 1.65億 USD | 1.62億 USD | 1.27億 USD |
| 売上原価 | 6476.8万 USD | 5650万 USD | 5817.4万 USD | 5510.5万 USD | 4127.8万 USD |
| 粗利益 | 1.46億 USD | 1.1億 USD | 1.07億 USD | 1.07億 USD | 8540.4万 USD |
| 研究開発 | 2024.7万 USD | 1970.6万 USD | 2642.8万 USD | 2026.9万 USD | 1831.5万 USD |
| 販売・一般管理 | 1.65億 USD | 1.4億 USD | 1.46億 USD | 1.26億 USD | 9222.9万 USD |
| 営業費用 | 1.85億 USD | 1.6億 USD | 1.72億 USD | 1.46億 USD | 1.11億 USD |
| 受取利息 | 42.3万 USD | 147.7万 USD | 102万 USD | 8.7万 USD | 2.3万 USD |
| 支払利息 | 2525.6万 USD | 2082.9万 USD | 1539.3万 USD | 1176万 USD | 906.2万 USD |
| 減価償却費と償却費 | 1047.4万 USD | 757.7万 USD | 488.3万 USD | 433.9万 USD | 412.4万 USD |
| 営業利益 | −3900.8万 USD | −4998.7万 USD | −6502.6万 USD | −3965.8万 USD | −2514万 USD |
| 純利益 | −5106.4万 USD | −8459.6万 USD | −7850.2万 USD | −7520.9万 USD | −4113.9万 USD |
会社概要が更新されました 2026年10月12日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$102
上昇余地（65.40%）この株式へのエクスポージャーを報告している上場投資信託です。
iShares Russell 2000 ETFIWM4321.58万0.06%787.4億 USD0.19%$278.94+0.49%
iShares Russell 2000 Growth ETFIWO1514.95万0.11%139.17億 USD0.24%$356.78+0.94%
Vanguard Russell 2000 ETFVTWO1080.03万0.06%180億 USD0.06%$112.66+0.50%
T. Rowe Price Small-Mid Cap ETFTMSL537.79万0.18%30.87億 USD0.55%$41.18+0.59%
Vanguard Health Care ETFVHT391.67万0.02%220億 USD0.09%$319.01+1.64%
Simplify Health Care ETFPINK341.18万1.07%3.19億 USD0.51%$38.527+2.57%
First Trust Small Cap Growth AlphaDEX FundFYC328.79万0.24%13.49億 USD0.70%$115.36+1.35%
Vanguard Russell 2000 Growth ETFVTWG205.06万0.12%17億 USD0.06%$260.49+0.91%iShares Russell 2000 ETFIWMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOT. Rowe Price Small-Mid Cap ETFTMSLVanguard Health Care ETFVHTSimplify Health Care ETFPINKFirst Trust Small Cap Growth AlphaDEX FundFYCVanguard Russell 2000 Growth ETFVTWGAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
